These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 22935407)

  • 21. Treating fatigue.
    Lapierre Y; Hum S
    Int MS J; 2007 Jun; 14(2):64-71. PubMed ID: 17686346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.
    Geisler MW; Sliwinski M; Coyle PK; Masur DM; Doscher C; Krupp LB
    Arch Neurol; 1996 Feb; 53(2):185-8. PubMed ID: 8639070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
    Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between fatigue and other clinical features of multiple sclerosis.
    Mills RJ; Young CA
    Mult Scler; 2011 May; 17(5):604-12. PubMed ID: 21135018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis.
    Yusuf A; Koski L
    J Neurol Sci; 2013 Jul; 330(1-2):4-9. PubMed ID: 23651867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ['Fatigue' in multiple sclerosis].
    Zimmermann C; Hohlfeld R
    Nervenarzt; 1999 Jun; 70(6):566-74. PubMed ID: 10412704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
    J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amantadine influences cognitive processing in patients with multiple sclerosis.
    Sailer M; Heinze HJ; Schoenfeld MA; Hauser U; Smid HG
    Pharmacopsychiatry; 2000 Jan; 33(1):28-37. PubMed ID: 10721881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathophysiology and treatment of fatigue in multiple sclerosis].
    Boërio D; Lefaucheur JP; Hogrel JY; Créange A
    Rev Neurol (Paris); 2006 Mar; 162(3):311-20. PubMed ID: 16585886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fatigue in multiple sclerosis].
    Dworzańska E; Mitosek-Szewczyk K; Stelmasiak Z
    Neurol Neurochir Pol; 2009; 43(1):71-6. PubMed ID: 19353446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial.
    Lappin MS; Lawrie FW; Richards TL; Kramer ED
    Altern Ther Health Med; 2003; 9(4):38-48. PubMed ID: 12868251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
    Foroughipour M; Bahrami Taghanaki HR; Saeidi M; Khazaei M; Sasannezhad P; Shoeibi A
    Acupunct Med; 2013 Mar; 31(1):27-30. PubMed ID: 23151355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional treatments in multiple sclerosis.
    Courtney AM; Castro-Borrero W; Davis SL; Frohman TC; Frohman EM
    Curr Opin Neurol; 2011 Jun; 24(3):250-4. PubMed ID: 21455067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatigue and quality of life in pediatric multiple sclerosis.
    MacAllister WS; Christodoulou C; Troxell R; Milazzo M; Block P; Preston TE; Bender HA; Belman A; Krupp LB
    Mult Scler; 2009 Dec; 15(12):1502-8. PubMed ID: 19965517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatigue and sleep disturbance following traumatic brain injury--their nature, causes, and potential treatments.
    Ponsford JL; Ziino C; Parcell DL; Shekleton JA; Roper M; Redman JR; Phipps-Nelson J; Rajaratnam SM
    J Head Trauma Rehabil; 2012; 27(3):224-33. PubMed ID: 22573041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central and peripheral fatigue: exemplified by multiple sclerosis and myasthenia gravis.
    Cantor F
    PM R; 2010 May; 2(5):399-405. PubMed ID: 20656621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis.
    Zwibel HL
    Adv Ther; 2009 Dec; 26(12):1043-57. PubMed ID: 20082242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which cognitions and behaviours mediate the positive effect of cognitive behavioural therapy on fatigue in patients with multiple sclerosis?
    Knoop H; van Kessel K; Moss-Morris R
    Psychol Med; 2012 Jan; 42(1):205-13. PubMed ID: 21672300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amantadine and fatigue of multiple sclerosis.
    Kemp BA; Gora ML
    Ann Pharmacother; 1993; 27(7-8):893-5. PubMed ID: 8364274
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
    Ledinek AH; Sajko MC; Rot U
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S86-9. PubMed ID: 24321164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.